human
respiratori
syncyti
viru
rsv
major
caus
sever
lower
respiratori
tract
infect
infant
immunocompromis
patient
elderli
rsv
fusion
f
protein
mediat
fusion
viral
envelop
target
cell
membran
viru
entri
primari
target
antivir
drug
vaccin
develop
f
protein
contain
two
heptad
repeat
region
peptid
correspond
region
form
sixhelix
bundl
structur
thought
play
critic
role
membran
fusion
howev
character
sixhelix
bundl
format
nativ
rsv
f
protein
hinder
fact
trigger
f
protein
conform
chang
yet
identifi
demonstr
rsv
f
protein
surfac
infect
cell
undergo
conform
chang
follow
exposur
elev
temperatur
result
format
sixhelix
bundl
structur
first
gener
character
sixhelixbundlespecif
antibodi
rais
recombin
peptid
model
rsv
f
protein
sixhelix
bundl
structur
use
antibodi
probe
monitor
rsv
f
protein
sixhelix
bundl
format
respons
divers
array
potenti
trigger
conform
chang
found
exposur
membraneanchor
rsv
f
protein
elev
temperatur
suffici
trigger
sixhelix
bundl
format
antibodi
bind
sixhelix
bundl
conform
detect
flow
cytometri
cellsurfac
immunoprecipit
rsv
f
protein
none
treatment
includ
interact
number
potenti
receptor
result
signific
bind
sixhelix
bundlespecif
antibodi
conclud
nativ
untrigg
rsv
f
protein
exist
metast
state
convert
vitro
stabl
fusogen
sixhelix
bundl
conform
increas
thermal
energi
find
help
better
defin
mechan
rsv
fmediat
membran
fusion
import
implic
identif
therapeut
strategi
vaccin
target
rsv
f
protein
conform
chang
human
respiratori
syncyti
viru
rsv
envelop
negativesens
ssrna
viru
pneumoviru
group
paramyxovirida
famili
collin
et
al
rsv
major
caus
pediatr
respiratori
diseas
result
sever
lower
respiratori
tract
infect
infant
immunocompromis
patient
elderli
collin
et
al
effect
vaccin
avail
rsv
current
approv
antivir
therapi
rsv
infect
limit
ribavirin
broadspectrum
antivir
drug
limit
efficaci
prophylact
treatment
antirsv
monoclon
antibodi
palivizumab
effect
reduc
sever
diseas
recommend
highrisk
patient
johnson
et
al
groothui
et
al
pollack
groothui
therefor
develop
new
therapi
treatment
rsv
infect
high
prioriti
rsv
enter
cell
bind
target
cell
surfac
fuse
envelop
plasma
membran
target
cell
three
viral
glycoprotein
envelop
surfac
attach
glycoprotein
g
fusion
f
protein
small
hydrophob
sh
protein
heminway
et
al
howev
sever
line
evid
indic
f
fusion
protein
necessari
suffici
viru
entri
cell
fusion
karron
et
al
bukreyev
et
al
kahn
et
al
teecharpornkul
et
al
thu
critic
role
f
protein
viru
entri
along
fact
f
highli
conserv
major
antigen
neutral
antibodi
make
attract
therapeut
target
johnson
et
al
eckert
et
al
collin
et
al
zhao
et
al
rsv
f
protein
synthes
kda
precursor
process
proteolyt
cleavag
transgolgi
complex
yield
two
disulphidelink
subunit
fig
anderson
et
al
collin
mottet
collin
et
al
matur
f
protein
express
homotrim
cellsurfac
calder
et
al
ectodomain
transmembran
subunit
contain
two
heptad
repeat
region
ntermin
fusion
peptid
fig
collin
et
al
process
precursor
propos
gener
metast
complex
zhao
et
al
one
propos
model
receptor
bind
trigger
conform
chang
metast
f
protein
result
insert
ntermin
fusion
peptid
target
cell
membran
heptad
repeat
region
interact
form
sixhelix
bundl
structur
carr
et
al
eckert
kim
accord
model
format
sixhelix
bundl
structur
facilit
membran
fusion
bring
viral
cellular
membran
close
apposit
chan
kim
eckert
kim
russel
et
al
presenc
heptad
repeat
region
capabl
associ
form
sixhelix
bundl
structur
featur
sever
envelop
viru
fusion
protein
suggest
common
membran
fusion
mechan
lamb
hernandez
et
al
melikyan
et
al
skehel
wiley
lamb
kolakofski
support
model
peptid
correspond
rsv
f
protein
region
n
c
peptid
respect
shown
form
sixhelix
coiledcoil
bundl
structur
wherein
three
c
peptid
pack
antiparallel
fashion
outer
groov
central
n
peptid
trimer
coiledcoil
fig
zhao
et
al
matthew
et
al
lawlessdelmedico
et
al
model
also
support
part
fact
c
peptid
often
potent
inhibitor
fusion
mediat
viral
fusion
protein
includ
rsv
f
protein
lambert
et
al
wang
et
al
case
hiv
c
peptid
inhibitor
shown
interact
region
hiv
fusion
protein
intermedi
stage
conform
chang
form
deadend
hybrid
sixhelix
bundl
structur
kilgor
et
al
one
hiv
c
peptid
inhibitor
enfuvirtid
approv
treatment
hiv
infect
thu
inhibit
viral
fusion
protein
sixhelix
bundl
format
valid
therapeut
approach
treatment
viral
diseas
wild
et
al
wild
et
al
chan
kim
eckert
et
al
zhao
et
al
descript
sixhelix
bundl
structur
form
n
c
peptid
deriv
rsv
f
protein
along
fact
rsv
c
peptid
potent
inhibit
fusion
suggest
rsv
f
protein
undergo
conform
chang
fusion
analog
describ
hiv
influenza
relat
viral
system
electron
microscopi
studi
rsv
f
protein
reveal
trypsin
treatment
caus
chang
conform
lollipopshap
structur
coneshap
structur
thought
repres
nativ
fusionact
state
respect
calder
et
al
howev
yet
demonstr
directli
nativ
membraneanchor
rsv
f
protein
trigger
undergo
conform
chang
lead
format
sixhelix
bundl
structur
inde
yet
known
trigger
conform
chang
sinc
like
hiv
rsv
fusion
take
place
cell
surfac
ph
independ
srinivasakumar
et
al
collin
et
al
presum
bind
f
protein
cellular
receptor
trigger
conform
chang
although
sever
ligand
identifi
bind
rsv
f
protein
remain
unclear
whether
one
ligand
bona
fide
receptor
rsv
pastey
et
al
behera
et
al
sano
et
al
hallak
et
al
lack
system
studi
nativ
rsv
f
protein
sixhelix
bundl
format
hinder
develop
therapeut
target
f
protein
conform
chang
present
studi
gener
conformationspecif
antibodi
recombin
peptid
immunogen
model
rsv
f
protein
sixhelix
bundl
structur
show
low
level
rsv
f
protein
sixhelix
bundl
conform
exist
surfac
rsvinfect
cell
cultur
activ
undergo
fusion
util
sixhelixbundlespecif
antibodi
probe
character
potenti
trigger
f
protein
conform
chang
determin
elev
temperatur
serv
effici
vitro
trigger
f
protein
conform
chang
lead
sixhelix
bundl
format
implic
find
develop
antivir
therapeut
vaccin
target
rsv
f
protein
discuss
order
gener
antibodi
rsv
peptid
correspond
hr
region
rsv
f
protein
express
gener
immunogen
mimic
rsvf
fusion
core
structur
first
engin
codonoptim
synthet
bacteri
express
construct
express
link
n
c
singlechain
peptid
nc
n
peptid
c
peptid
use
sequenc
deriv
work
zhao
et
al
zhao
et
al
figur
synthet
cdna
construct
select
nucleotid
residu
code
sequenc
wildtyp
rsv
f
cdna
access
replac
residu
favor
optim
express
e
coli
fig
recombin
rsv
peptid
n
c
nc
singlechain
express
histidin
tag
fusion
peptid
e
coli
fig
histag
cleav
factorxa
peptid
desalt
lyophil
resuspend
concentr
mgml
water
link
singlechain
nc
peptid
mixtur
individu
n
c
peptid
nc
hypothes
form
complex
vitro
mimic
authent
structur
form
due
coiledcoil
interact
rsvf
hr
domain
fusion
process
glycinerich
peptid
insert
n
c
domain
allow
fold
interact
arm
nc
peptid
fig
recombin
rsv
peptid
analyz
sdspage
factorxa
cleavag
determin
approxim
molecular
weight
larger
size
histag
peptid
due
presenc
uncleav
trx
thrombin
stag
encod
leader
sequenc
preced
engin
iegr
factor
xa
rsv
peptid
n
c
nc
fig
factorxa
enzymemedi
cleavag
histag
peptid
releas
freen
c
nc
peptid
respect
fig
predict
molecular
weight
n
c
nc
aa
peptid
base
amino
acid
aa
sequenc
kda
respect
fig
migrat
pattern
rsv
peptid
rel
kda
control
peptid
molecular
weight
marker
coincid
well
predict
molecular
weight
compar
fig
fig
determin
whether
antibodi
rsv
could
recogn
recombin
peptid
immunoblot
recombin
peptid
probe
use
rsv
neutral
polyclon
serum
polyclon
serum
recogn
n
nc
peptid
thu
confirm
peptid
contain
authent
f
protein
epitop
fig
surprisingli
c
peptid
appear
react
serum
faint
background
band
seen
like
attribut
crossreact
contamin
bacteri
protein
one
possibl
explan
observ
presenc
conserv
nlink
glycosyl
site
aa
nq
within
cpeptid
region
domain
fusion
protein
fig
collin
et
al
zimmer
et
al
perhap
presenc
carbohydr
side
chain
make
region
poorli
antigen
altern
region
may
buri
within
nativ
untrigg
rsv
f
protein
oligom
inaccess
circul
antibodi
studi
solubl
f
protein
suggest
latter
explan
unlik
sinc
region
propos
form
stalk
structur
prefus
state
lamb
jardetzki
c
n
peptid
report
potent
inhibit
rsv
fusion
infect
lambert
et
al
gao
et
al
determin
whether
peptid
gener
antivir
activ
test
peptid
n
c
nc
nc
mixtur
abil
inhibit
rsv
infect
syncytia
format
vitro
doserespons
assay
consist
previou
observ
lambert
et
al
wang
et
al
n
c
peptid
found
inhibit
rsv
infect
data
shown
also
consist
previou
report
c
peptid
found
potent
n
peptid
ic
respect
exist
prehairpin
intermedi
conform
rsv
strongli
support
observ
other
rsv
infect
potent
inhibit
hrc
peptid
lambert
et
al
wang
et
al
found
link
peptid
nc
exhibit
notic
antivir
activ
data
shown
similarli
mix
nand
cpeptid
togeth
equimolar
ratio
nc
result
loss
antivir
activ
either
peptid
presum
due
structur
format
data
shown
circular
dichroism
reveal
rsv
peptid
nc
equimolar
mixtur
n
c
peptid
nc
assum
helic
characterist
sixhelix
bundl
structur
circular
dichroism
cd
perform
determin
whether
peptid
nc
nc
solut
structur
similar
predict
rsv
fusion
core
previou
studi
wild
et
al
therefor
analyz
helic
nc
peptid
mixtur
n
c
nc
cd
spectra
sampl
peptid
nc
pb
display
doubl
minima
characterist
high
degre
secondari
structur
found
complex
fig
mean
molar
elipt
valu
indic
condit
experi
protein
helic
similar
result
obtain
mixtur
individu
nand
cpeptid
construct
data
shown
data
indic
complex
form
recombin
rsv
peptid
nc
nc
model
structur
manner
similar
peptid
util
previou
studi
lawlessdelmedico
et
al
zhao
et
al
peptid
elisa
demonstr
antibodi
gener
recombin
peptid
complex
specif
epitop
establish
peptid
possess
characterist
structur
recombin
peptid
complex
nc
nc
use
immunogen
rais
antibodi
would
recogn
epitop
gener
rsv
fmediat
fusion
process
three
guinea
pig
immun
immunogen
nc
nc
mix
peptid
use
approach
previous
gener
antibodi
hiv
structur
form
follow
trigger
derosni
et
al
furuta
et
al
peptidebas
indirect
elisa
use
initi
character
antiserum
peptid
nc
nc
highli
immunogen
yield
rel
hightit
antiserum
fig
design
antibodi
respons
direct
primarili
peptid
complex
nc
nc
rather
individu
peptid
n
c
fig
furthermor
reactiv
antiserum
peptid
nc
nc
could
complet
adsorb
either
immunogen
nc
nc
free
peptid
n
c
fig
observ
demonstr
antibodi
predominantli
recogn
epitop
antiserum
react
peptid
complex
correspond
hiv
indic
specif
rsv
data
shown
result
also
support
find
hiv
system
wherein
polyclon
antiserum
display
similar
specif
peptid
complex
derosni
et
al
collect
result
demonstr
antiserum
gener
nc
nc
peptid
predominantli
complexspecif
therefor
suitabl
probe
rsvf
structur
sinc
antibodi
display
higher
titer
fig
well
lower
cross
reactiv
free
peptid
n
c
fig
antiserum
fig
use
character
antiserum
use
probe
lysat
strip
prepar
rsv
infect
cell
react
protein
molecular
weight
kda
subunit
predominantli
kda
protein
fig
suggest
antisera
recogn
epitop
rsv
f
protein
immunoprecipit
ip
experi
antiserum
immunoprecipit
subunit
rsvinfect
cell
lysat
form
whatsoev
observ
result
consist
antibodi
epitop
locat
subunit
fig
lack
bind
interest
sinc
studi
solubl
f
protein
suggest
cleavag
f
precursor
requir
adopt
postfus
conform
lamb
jardetzki
may
requir
format
differ
solubl
nativ
membranebound
f
protein
ruizarguello
et
al
yin
et
al
yin
et
al
convers
reactiv
antibodi
form
rsv
f
protein
western
blot
fig
could
either
nonspecif
result
small
amount
antibodi
uncomplex
n
c
compon
bind
denatur
potenti
collect
find
along
result
peptid
elisa
strongli
suggest
epitop
recogn
antiserum
rsv
structur
fig
fig
next
employ
cellsurfac
immunoprecipit
determin
epitop
could
found
surfac
rsvinfect
cell
activ
undergo
cell
fusion
use
serum
subunit
immunoprecipit
surfac
rsv
infect
cell
fig
order
determin
immunoprecipit
cellsurfac
inde
conform
adsorb
antiserum
peptid
n
c
nc
nc
respect
use
serum
cellsurfac
ip
experi
result
show
adsorpt
antiserum
nc
nc
data
shown
peptid
mimic
rsv
f
structur
complet
abolish
capac
antiserum
immunoprecipit
protein
wherea
adsorpt
peptid
n
c
alon
prevent
bind
fig
peptideadsorpt
cellsurfac
ip
result
along
peptideelisa
bind
data
demonstr
antibodi
conformationspecif
epitop
therefor
use
detect
final
conform
state
rsv
f
protein
result
provid
proofofconcept
start
syntheticpeptid
immunogen
mimic
rsv
f
structur
possibl
gener
antibodi
specif
bind
epitop
creat
surfac
rsvinfect
cell
undergo
fusion
use
flow
cytometri
stain
rsvinfect
cell
antiserum
detect
presenc
low
level
f
protein
conform
cellsurfac
fig
mean
fluoresc
due
antibodi
bind
epitop
significantli
lower
comparison
total
f
protein
detect
use
monoclon
antibodi
fig
data
gener
use
flow
cytometri
correl
well
cellsurfac
ip
result
suggest
low
level
f
protein
exist
surfac
rsvinfect
cell
use
flow
cytometri
rapidli
rule
possibl
follow
condit
reagent
would
trigger
conform
chang
cellsurfac
express
rsv
f
fusion
activ
sixhelix
bundl
format
addit
report
finteract
protein
rhoa
glycosaminoglycan
heparin
heparan
sulphat
dextran
sulphat
chondroitin
b
human
bovin
lactoferrin
report
interact
g
f
glycoprotein
exposur
differ
ph
trypsin
disulphid
bond
reduc
agent
dtt
denatur
agent
sd
data
shown
previou
work
use
solubl
form
f
protein
parainfluenza
viru
type
demonstr
effect
temperatur
conform
state
protein
connolli
et
al
determin
elev
temperatur
could
trigger
format
nativ
rsv
f
protein
incub
rsvinfect
cell
min
rang
temperatur
prior
stain
antibodi
follow
incub
temperatur
specif
increas
stain
rsvinfect
cell
uninfect
control
cell
observ
fig
data
shown
repeat
test
effect
temperatur
trigger
min
incub
use
thermocycl
reveal
trigger
reach
plateau
fig
level
stain
antibodi
almost
equival
observ
antif
monoclon
antibodi
posit
control
data
shown
suggest
larg
proport
total
popul
f
protein
express
cell
surfac
trigger
condit
order
identifi
optim
time
trigger
rsv
infect
vero
cell
incub
variou
length
time
hour
prior
stain
exposur
min
durat
result
dramaticrapid
increas
trigger
fig
small
gradual
increas
trigger
observ
beyond
min
exposur
minut
effect
subsid
data
along
result
temperaturecours
experi
fig
demonstr
short
incub
minut
suffici
trigger
optim
format
surfac
rsvinfect
cell
trigger
compar
four
differ
cell
line
vero
hela
result
demonstr
best
combin
f
express
trigger
signaltonois
observ
vero
cell
data
shown
order
confirm
incub
deleteri
effect
cellmembran
rsvinfect
vero
cell
treat
hour
stain
antibodi
recogn
two
intracellular
constitu
rho
found
intracellular
face
plasma
membran
golgicomplex
sigma
golgispecif
antibodi
observ
flow
cytometri
stain
rhoa
golgicomplex
dramat
increas
uninfect
vero
cell
follow
treatment
detergentcontain
buffer
perm
bd
bioscienc
wherea
increas
observ
follow
incub
hr
absenc
deterg
data
shown
result
demonstr
signific
cellpermeabil
occur
trigger
detect
temperatur
instead
due
format
cellsurfac
express
f
protein
specif
stain
follow
trigger
confirm
experi
show
signific
stain
background
observ
follow
adsorpt
antibodi
complex
nc
peptid
mixtur
fig
cellsurfac
immunoprecipit
experi
perform
antiserum
incub
rsvinfect
cell
increas
temperatur
min
follow
trigger
step
unbound
antibodi
wash
away
immun
complex
immunoprecipit
shown
fig
amount
rsv
f
protein
cell
surfac
recogn
antiserum
significantli
increas
temperatur
c
highest
level
pull
c
result
consist
result
present
fig
flow
cytometri
experi
confirm
increas
antibodi
bind
detect
elev
temperatur
specif
rsv
f
protein
confirm
specif
antibodi
bind
sixhelix
bundl
conform
rsv
f
follow
temperatur
trigger
cellsurfac
ip
experi
perform
nc
antiserum
preincub
either
n
c
nc
singlechain
peptid
mixtur
n
c
peptid
nc
prior
incub
rsvinfect
cell
c
min
shown
virtual
reactiv
nc
antiserum
temperaturetrigg
rsv
f
protein
adsorb
nc
singlechain
peptid
equimolar
mixtur
nc
peptid
complex
wherea
n
c
peptid
alon
fail
adsorb
antibodi
result
confirm
elev
temperatur
trigger
rsv
f
protein
format
surfac
infect
cell
studi
describ
gener
reagent
identif
system
permit
studi
format
directli
nativ
membraneanchor
f
protein
express
surfac
rsvinfect
cell
use
conformationspecif
antibodi
rsv
f
structur
directli
demonstr
elev
temperatur
effici
trigger
f
protein
conform
chang
flow
cytometrybas
assay
describ
report
attract
start
point
develop
novel
strategi
discoveri
rsv
fusion
inhibitor
previous
use
similar
approach
success
studi
format
follow
trigger
identifi
small
molecul
inhibitor
fusion
salzwedel
et
al
unpublish
result
furuta
et
al
derosni
et
al
physiolog
trigger
activ
conform
chang
rsv
f
known
activ
paramyxoviru
f
protein
neutral
ph
trigger
threestep
process
includ
bind
viral
receptorbind
protein
hn
h
cellular
receptor
interact
hn
f
conform
chang
f
mediat
membran
fusion
case
hiv
fusion
protein
trigger
bind
associ
subunit
receptor
target
cell
surfac
hernandez
et
al
sinc
like
hiv
rsv
fusion
take
place
cell
surfac
ph
independ
collin
et
al
like
f
protein
also
interact
cellsurfac
receptor
although
receptor
yet
identifi
could
test
hydrostat
pressur
report
effect
induc
fusion
activ
state
due
need
special
equip
gaspar
et
al
similarli
could
test
urea
guanidin
hcl
system
due
deleteri
effect
cell
earli
studi
discov
low
ph
trigger
effect
influenza
hemagglutinin
ha
could
substitut
elev
temperatur
rang
wharton
haywood
boyer
ruigrok
heattrigg
conform
chang
ha
coincid
format
fusogen
conform
biochem
indistinguish
low
phtrigger
conform
carr
et
al
studi
suggest
us
elev
temperatur
could
potenti
serv
trigger
rsv
f
protein
use
antibodi
probe
observ
flow
cytometri
cellsurfac
ip
experi
exposur
rsv
infect
cell
temperatur
min
suffici
caus
increas
format
conform
f
fig
conclud
elev
temperatur
could
serv
effici
vitro
trigger
format
rsvf
one
caveat
studi
complet
rule
possibl
antibodi
may
recogn
conform
domain
repres
free
c
peptid
epitop
could
potenti
unmask
partial
denatur
incub
elev
temperatur
may
faith
repres
conform
f
protein
relat
authent
conform
chang
altern
possibl
antibodi
may
detect
intermedi
conform
f
protein
rather
postfus
structur
howev
consid
scenario
unlik
given
result
obtain
author
demonstr
form
protein
could
trigger
undergo
conform
chang
stabl
postfus
state
heat
rang
upon
trigger
gcnt
associ
liposom
membran
form
rosett
lost
gain
reactiv
conformationspecif
antibodi
predict
recogn
preor
postfus
conform
state
respect
chang
shape
solubl
protein
prefus
ballandstem
elong
postfus
golfte
shape
also
observ
electron
microscopi
connolli
et
al
thu
find
elev
temperatur
serv
surrog
trigger
rsv
f
conform
chang
consist
previou
studi
f
protein
conform
chang
paramyxoviru
system
lamb
jardetzki
studi
process
conform
chang
fusion
protein
divers
group
envelop
virus
includ
influenza
ha
hiv
lead
develop
springload
trap
model
carr
russel
model
suggest
nonfusogen
neutral
ph
conform
viral
fusion
glycoprotein
vfgp
includ
nativ
complex
paramyxovirus
rsv
exist
kinet
trap
highenergi
state
energi
releas
result
conform
chang
protein
agreement
springtrap
model
neutral
ph
heat
urea
pressur
loosen
nativ
nonfusogen
form
caus
transit
spontan
fusogen
form
suggest
nativ
state
vfgp
metast
carr
et
al
carr
et
al
paterson
et
al
wharton
et
al
gaspar
et
al
epand
et
al
studi
also
propos
physiolog
trigger
ph
chang
receptor
bind
fulfil
common
energi
requir
perform
work
membran
fusion
could
satisfi
directli
increas
temperatur
destabil
forc
urea
pressur
patterson
et
al
wharton
et
al
wharton
et
al
carr
et
al
haywood
et
al
ruigrok
et
al
epand
et
al
seth
et
al
energi
releas
format
use
perform
work
membran
fusion
melikyan
et
al
demonstr
heat
trigger
format
structur
rsv
fusion
protein
consist
nativ
state
rsv
f
protein
exist
metast
state
find
therefor
extend
metast
hypothesi
rsv
member
pneumoviru
genu
famili
paramyxovirida
assay
system
describ
report
potenti
applic
test
futur
rsv
receptor
candid
measur
trigger
effect
f
protein
conform
chang
similarli
approach
could
use
studi
requir
format
nativ
rsv
f
exampl
rsv
g
sh
protein
influenc
effect
undergo
conform
chang
cleav
thermal
trigger
approach
could
also
adapt
studi
conform
chang
fusion
protein
virus
receptor
yet
identifi
trigger
event
conform
chang
rsv
f
protein
lead
format
attract
antivir
target
sinc
disrupt
key
step
prevent
f
protein
mediat
membran
fusion
treat
hiv
infect
c
peptid
inhibitor
enfuvirtid
approv
target
hiv
fusion
protein
intermedi
stage
conform
chang
form
deadend
hybrid
sixhelix
bundl
structur
wild
et
al
kilgor
et
al
matthew
et
al
thu
inhibit
viral
fusion
protein
sixhelix
bundl
format
valid
therapeut
approach
treatment
viral
diseas
rsv
antibodi
probe
temperatur
trigger
techniqu
describ
could
appli
toward
develop
highthroughput
drug
screen
assay
identifi
small
molecul
drug
specif
block
conform
chang
fusion
protein
proofofconcept
idea
provid
identif
influenza
viru
fusion
inhibitor
capabl
block
temperatureinduc
format
influenza
viru
ha
yoshimoto
et
al
vero
cell
strain
human
rsv
obtain
atcc
cell
cultur
dulbecco
modifi
eagl
medium
fetal
bovin
serum
contain
antibiot
viru
propag
titrat
vero
cell
follow
antibodi
use
antirsv
polyclon
antibodi
biodesign
antif
protein
mab
serotec
antif
protein
mab
chemicon
antig
protein
mab
chemicon
antirhoa
mab
santa
cruz
biotechnolog
antigolgi
mab
sigma
donkey
antigoat
igghrp
chemicon
synthet
gene
encod
heptad
repeat
region
n
c
rsv
f
protein
strain
access
number
design
base
work
zhao
et
al
zhao
et
al
codon
optim
optim
express
escherichia
coli
fig
cdna
construct
encod
heptad
repeat
region
amino
acid
residu
rsv
f
amino
acid
residu
rsv
f
link
via
glycinerich
linker
gener
fig
b
c
briefli
seri
overlap
complementari
oligonucleotid
span
entir
length
either
n
c
code
sequenc
design
codon
within
oligo
sequenc
bias
optim
express
e
coli
fig
oligo
anneal
extend
appropri
order
success
pcr
reaction
form
two
complet
doublestrand
dna
encod
either
n
peptid
c
peptid
result
pcr
product
reamplifi
final
pcr
reaction
use
upstream
primer
encod
bam
hifactorxa
cleavag
sequenc
residu
iegr
end
revers
primer
encod
restrict
site
hind
iii
end
final
pcr
product
reaction
clone
bam
hihind
iii
site
bacteri
express
vector
novagen
gener
cdna
respect
link
cdna
fig
construct
first
amplifi
individu
cdna
fragment
separ
pcr
reaction
use
complementari
overlap
primer
encod
half
interven
linker
sequenc
well
uniqu
kpn
site
end
result
pcr
fragment
encod
ligat
togeth
kpn
site
yield
fragment
encod
join
via
glycinerich
linker
nc
fig
ligat
amplifi
pcr
reaction
use
primer
encod
end
primer
encod
end
final
product
clone
via
bam
hihind
iii
vector
yield
cdna
encod
singlechain
nc
peptid
fig
b
c
construct
sequenc
entireti
hexahistidin
tag
encod
vector
allow
histidin
affin
purif
fusion
peptid
recombin
rsv
peptid
express
histidinetag
fusion
protein
e
coli
fig
b
c
fig
plasmid
transform
ecoli
strain
plyss
novagen
protein
express
individu
coloni
transform
bacteria
inocul
luriabertani
lb
broth
grown
optic
densiti
nm
protein
express
induc
mm
hr
cell
harvest
pellet
centrifug
cell
pellet
lyse
benzonas
reagent
novagen
lysat
clarifi
centrifug
histidinetag
fusion
protein
lysat
captur
ni
affin
column
elut
histidinetag
fusion
protein
dialyz
factorxa
cleavag
buffer
trishcl
ph
cacl
order
set
factorxa
digest
fusion
protein
digest
factorxa
wtwt
ratio
proteas
tag
protein
room
temperatur
remov
leader
peptid
histidin
tag
residu
leader
peptidehistidin
tag
remov
cleavag
mixtur
pass
mixtur
ni
affin
column
flowthrough
contain
rsv
peptid
n
c
nc
fig
n
nc
peptid
desalt
pass
sephadex
column
peptid
lyophil
resuspend
ultra
pure
water
rsv
peptid
n
c
nc
adjust
mgml
final
concentr
purifi
n
c
nc
peptid
along
histidinetag
form
separ
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
use
polyacrylamid
bistri
novex
gel
invitrogen
alongsid
multimark
molecular
weight
marker
commerci
synthes
peptid
known
molecular
weight
kda
protein
detect
coomassi
blue
stain
order
ascertain
synthet
peptid
could
recogn
antirsv
antibodi
purifi
n
c
nc
peptid
separ
sdspage
transfer
nitrocellulos
membran
probe
goat
polyclon
serum
antibodi
bind
detect
use
horseradish
peroxidaseconjug
antigoat
secondari
antibodi
ecl
chemiluminesc
detect
system
amersham
pharmacia
biotech
n
c
nc
peptid
equimolar
mixtur
n
c
peptid
nc
test
doserespons
assay
abil
inhibit
rsvmediat
cell
fusion
infect
vitro
use
modif
rsv
microneutr
assay
johnson
briefli
tcid
rsv
mix
variou
concentr
rsv
peptid
preincub
room
temperatur
peptideviru
mixtur
ad
vero
cell
monolay
plate
cellswel
plate
incub
day
score
visual
inhibit
virusmedi
cell
kill
cd
measur
obtain
aviv
associ
model
spectropolarimet
calibr
standard
solut
acid
per
wild
et
al
sampl
contain
total
concentr
peptid
either
nc
nc
peptid
mixtur
nacl
mm
potassium
phosphat
adjust
ph
spectra
collect
mm
bandwidth
nm
step
size
time
constant
either
cell
blankcorrect
data
smooth
thirdord
polynomi
function
thermoelectr
cell
holder
accur
within
regul
sampl
temperatur
gener
antibodi
rsv
f
protein
structur
two
group
guinea
pig
immun
either
singlechain
peptid
nc
equimolar
mixtur
n
c
peptid
nc
anim
prime
subcutan
total
peptid
complet
freund
adjuv
boost
three
time
peptid
incomplet
freund
adjuv
preimmun
pi
sera
final
bleed
postimmun
store
indirect
elisa
establish
determin
reactiv
antinc
antinc
antiserum
rsv
peptid
n
c
nc
nc
mixtur
plate
vwr
cat
coat
ngwell
peptid
antigen
block
bsa
serum
sampl
ad
duplic
allow
incub
hr
incub
plate
wash
phosphataselabel
antiguinea
pig
secondari
antibodi
ad
dilut
incub
room
temperatur
secondari
antibodi
substrat
fast
pnitrophenyl
phosphat
sigma
ad
absorb
detect
nm
plate
reader
immunoblot
strip
prepar
rsvinfect
celllys
probe
antiserum
briefli
lysat
prepar
rsvinfect
vero
cell
rsv
protein
lysat
separ
sdspage
protein
transfer
nitrocellulos
membran
strip
prepar
probe
individu
differ
antibodi
rsv
protein
rsv
lysat
strip
probe
serum
dilut
milkpb
stripblot
probe
peroxidaseconjug
secondari
antibodi
follow
detect
use
ecl
chemiluminesc
detect
system
antisera
test
abil
immunoprecipit
rsv
protein
lysat
rsvinfect
cell
rsvinfect
vero
cell
lyse
ml
lysi
buffer
nonidet
tri
ph
clarifi
centrifug
rpm
minut
antiserum
ad
clarifi
lysat
incub
hr
protein
g
agaros
bead
invitrogen
ad
incub
hr
antigenantibodybead
complex
wash
five
time
wash
buffer
sd
igep
tri
ph
resuspend
proteinload
buffer
invitrogen
immunoprecipit
protein
separ
sdspage
protein
transfer
nitrocellulos
membran
membran
block
block
buffer
milkpb
probe
polyclon
antibodi
biodesign
intern
cat
dilut
block
buffer
blot
wash
probe
horseradish
peroxidaseconjug
donkey
antigoat
secondari
antibodi
chemicon
intern
cat
dilut
block
buffer
blot
wash
protein
detect
chemiluminesc
use
ecl
chemiluminesc
detect
system
cellsurfac
immunoprecipit
ip
use
select
immunoprecipit
fusion
protein
express
cellsurfac
rsv
infect
vero
cell
vero
cell
infect
rsv
moi
post
infect
rsv
infect
vero
monolay
wash
three
time
pb
resuspend
singlecel
suspens
use
enzymefre
celldissoci
buffer
invitrogen
cell
pellet
resuspend
stainwash
buffer
swb
pb
contain
nan
concentr
cellsml
cell
suspens
cell
use
cellsurfac
ip
primari
antibodi
monoclon
chemicon
intern
use
ip
antibodycel
mixtur
incub
follow
cell
wash
twice
pb
lyse
ml
lysi
buffer
clarifi
lysat
process
analyz
describ
lysateip
experi
immunoprecipit
protein
separ
use
sdspage
immunoblot
perform
lysat
ip
describ
temperatur
trigger
cellsurfac
ip
experi
master
mix
prepar
wherein
antibodi
ad
concentr
rsv
infect
vero
cell
cell
resuspend
swb
thorough
mix
aliquot
distribut
ml
pcr
tube
heat
treatment
thermocycl
cell
expos
elev
temperatur
rang
indic
temperatur
min
indic
time
period
follow
temperatur
treatment
subsequ
step
cellsurfac
ip
immunoblot
perform
describ
antibodi
stain
flow
cytometri
analysi
use
determin
level
f
protein
present
surfac
rsvinfect
cell
rsv
infect
vero
cell
resuspend
stainwash
buffer
concentr
cellsml
cell
cellsuspens
use
flow
cytometri
dilut
control
monoclon
antibodi
use
primari
antibodi
flow
cytometri
sampl
cell
incub
antiserum
hr
wash
twice
stainwash
buffer
secondari
antibodi
fitclabel
pig
antibodi
final
concentr
stainwash
buffer
ad
sampl
incub
min
cell
wash
twice
resuspend
stainwash
buffer
analyz
use
becton
dickinson
facscalibur
flow
cytomet
cellquest
softwar
flow
cytometri
format
use
screen
assay
search
potenti
trigger
rsv
format
test
wide
varieti
ligand
condit
recombin
gallina
et
al
expos
rsv
infect
vero
cell
elev
temperatur
vari
time
period
cours
identifi
temperatur
trigger
format
rsv
f
protein
integr
cell
follow
trigger
confirm
use
control
antibodi
intracellular
protein
rho
golgi
complex
order
compar
level
stain
obtain
obtain
follow
truecel
membran
permeabil
effect
use
cellpermeabil
buffer
facspermeabil
solut
becton
dickinson
permeabil
cell
prior
flow
cytometri
stain
rsv
infect
vero
cellsml
uninfect
vero
cell
treat
perm
buffer
per
manufactur
recommend
briefli
cell
expos
perm
solut
prepar
water
hr
follow
wash
stainwash
buffer
resuspend
back
origin
cellconcentr
ie
cellsml
cell
aliquot
cell
use
flow
cytometri
experi
stain
cellular
protein
rhoa
cellorganel
golgi
complex
determin
monoclon
antibodi
santa
cruz
biotechnolog
inc
sigma
respect
c
region
fusion
peptid
fp
transmembran
domain
tm
subunit
locat
addit
predict
heptad
repeat
shown
cleavag
site
design
locat
furin
cleavag
site
junction
respect
coomasi
stain
polyacrylamid
gel
show
molecular
weight
histidinetag
fusion
peptid
purifi
rsv
peptid
n
c
nc
releas
factor
xa
cleavag
correspond
histidinetag
fusion
protein
commerci
synthes
hiv
peptid
size
includ
comparison
b
serum
recogn
peptid
n
nc
c
peptid
immunoblot
arrow
indic
predict
migrat
cpeptid
recogn
serum
c
circular
dichroism
spectra
nc
singlechain
peptid
consist
solut
structur
doubl
minima
nm
characterist
high
level
helic
secondari
structur
found
cellsurfac
ip
demonstr
presenc
epitop
surfac
rsvinfect
cell
activ
undergo
fusion
cellsurfac
reactiv
epitop
adsorb
nc
nc
peptid
mixtur
individu
n
c
peptid
compar
trigger
lane
amount
subunit
immunoprecipit
follow
trigger
appear
somewhat
lower
observ
howev
still
appear
higher
observ
compar
lane
lane
respect
lane
control
show
f
express
rsvinfect
cell
immunoprecipit
antif
monoclon
antibodi
preimmun
serum
pi
immunoprecipit
relev
protein
either
uninfect
rsvinfect
cell
lane
b
specif
antiserum
bind
elev
temperatur
epitop
increas
amount
form
elev
temperatur
adsorb
correspond
peptid
antiserum
preadsorb
peptid
nc
n
c
nc
respect
pb
overnight
use
trigger
experi
describ
nc
nc
peptid
appear
almost
complet
adsorb
reactiv
antiserum
compar
lane
lane
adsorpt
antiserum
n
peptid
alon
lane
c
peptid
alon
lane
appear
significantli
impair
abil
immunoprecipit
subunit
